1,176
Participants
Start Date
January 6, 2022
Primary Completion Date
December 15, 2023
Study Completion Date
December 15, 2023
Research Site, Beijing
Research Site, Shanghai
Research Site, Suzhou
Research Site, Jinan
Research Site, Tianjin
Research Site, Changsha
Research Site, Guangzhou
Research Site, Chengdu
Research Site, Guangan
Research Site, Guangyuan
Research Site, Guangzhou
Research Site, Hangzhou
Research Site, Nantong
Research Site, Suzhou
Research Site, Taiyuan
Research Site, Xining
Lead Sponsor
AstraZeneca
INDUSTRY